An increased body mass index is not an adverse prognostic factor in persons undergoing autologous hematopoietic stem cell transplantation

Simple item page
dc.contributor.authorGuillermo J. Ruiz‐Delgado
dc.contributor.authorJacqueline Calderón-García
dc.contributor.authorCarlos Alarcón-Urdaneta
dc.contributor.authorGuillermo J. Ruíz‐Argüelles
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:21:41Z
dc.date.available2026-03-22T14:21:41Z
dc.date.issued2011
dc.descriptionCitaciones: 9
dc.description.abstractBetween May 1993 and December 2010, 106 persons underwent an autologous hematopoietic stem cell transplantation in the Centro de Hematologia y Medicina Interna of the Clinica Ruiz in Puebla, Mexico, using a simplified method of autografting avoiding cryopreservation of the stem cells and conducting the procedure fully on an outpatient basis. There were 39 patients with multiple myeloma, 31 with acute leukemia, 13 with ,
dc.identifier.urihttps://www.elsevier.es/en-revista-medicina-universitaria-304-articulo-an-increased-body-mass-index-X1665579611356402
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/46062
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofMedicina Universitaria
dc.sourceClínica Ruiz
dc.subjectHematopoietic stem cell transplantation
dc.subjectMedicine
dc.subjectMultiple myeloma
dc.subjectCryopreservation
dc.subjectStem cell
dc.subjectTransplantation
dc.subjectAutologous stem-cell transplantation
dc.subjectHaematopoiesis
dc.subjectOncology
dc.subjectBody mass index
dc.titleAn increased body mass index is not an adverse prognostic factor in persons undergoing autologous hematopoietic stem cell transplantation
dc.typearticle

Files

Collections

Artículo Científico Publicado